Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 10, 2021

SELL
$39.25 - $50.42 $4.9 Million - $6.3 Million
-124,956 Closed
0 $0
Q2 2021

Aug 09, 2021

SELL
$35.91 - $40.68 $1.86 Million - $2.11 Million
-51,885 Reduced 29.34%
124,956 $4.89 Million
Q1 2021

May 13, 2021

SELL
$33.49 - $37.77 $1.21 Million - $1.37 Million
-36,202 Reduced 16.99%
176,841 $6.41 Million
Q4 2020

Feb 08, 2021

SELL
$33.47 - $42.56 $7 Million - $8.9 Million
-209,093 Reduced 49.53%
213,043 $7.84 Million
Q3 2020

Oct 30, 2020

SELL
$31.75 - $37.25 $3.75 Million - $4.39 Million
-117,964 Reduced 21.84%
422,136 $15.5 Million
Q2 2020

Aug 05, 2020

SELL
$30.12 - $36.54 $719,868 - $873,306
-23,900 Reduced 4.24%
540,100 $17.7 Million
Q4 2019

Feb 07, 2020

BUY
$32.92 - $37.36 $98,760 - $112,080
3,000 Added 0.53%
564,000 $22.1 Million
Q3 2019

Nov 13, 2019

SELL
$32.49 - $42.13 $487,350 - $631,950
-15,000 Reduced 2.6%
561,000 $20.2 Million
Q2 2019

Jul 29, 2019

SELL
$36.98 - $41.52 $443,759 - $498,240
-12,000 Reduced 2.04%
576,000 $25 Million
Q1 2019

May 08, 2019

SELL
$37.5 - $41.2 $5.81 Million - $6.39 Million
-155,000 Reduced 20.86%
588,000 $25 Million
Q2 2018

Jul 30, 2018

BUY
$32.98 - $35.16 $2.74 Million - $2.92 Million
83,000 Added 12.58%
743,000 $27 Million
Q4 2017

Feb 06, 2018

SELL
$33.26 - $35.29 $1.16 Million - $1.24 Million
-35,000 Reduced 5.04%
660,000 $23.9 Million
Q3 2017

Oct 30, 2017

BUY
$31.0 - $34.15 $21.5 Million - $23.7 Million
695,000
695,000 $24.8 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $160B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Bp PLC Portfolio

Follow Bp PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bp PLC, based on Form 13F filings with the SEC.

News

Stay updated on Bp PLC with notifications on news.